Stock Taper 
STIM
$2.94
▼ DOWN 0.68% (-0.02)
KEY STATISTICS
Market Cap$204.59 M
52w High$3.71
52w Low$0.80
Dividend Yield—
Frequency—
P/E-6.68
Volume862.86K
Shares Out.69.59M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Daniel L. Reuvers
COMPENSATION 2026
Salary$728,000
Stock Awards$3,208,750
Incentive Plan Pay$412,776
All Other Comp.$15,538
Total$4,365,064
ABOUT
SECTOR
Healthcare
WENT PUBLIC
June 28, 2018
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
658
PRICE TARGET
Target High$5.00
Target Low$5.00
Target Median$5.00
Target Consensus$5.00
UPCOMING EARNINGS
DateNov 3, 2026
DayTuesday
Rev. Est.$40.33M
NOV
3
TUE
PRICE
$2.94 ▼ DOWN 0.68% (−$0.02)About Neuronetics, Inc.
https://www.neurostar.com ↗Neuronetics, Inc. develops and markets NeuroStar, a non-invasive transcranial magnetic stimulation system for treating major depressive disorder, primarily sold to psychiatrists in the U.S. and internationally.
INDUSTRY
Medical - Devices
A PRODUCT NEURONETICS, INC. IS KNOWN FOR
NeuroStar Advanced Therapy System
The NeuroStar Advanced Therapy System is a non-invasive TMS device treating depression, OCD, and anxious depression, providing a non-drug option for patients unresponsive to medication, and is Neuronetics' primary product for psychiatric and neuro...
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Service | — | — | $21.53M | $26.89M ▲ |
 | Product | — | — | $12.93M | $14.68M ▲ |
 | Medical Device Segment | $37.3M | $0 ▼ | — | — |
Revenue by Geography
| Map | REGION | Q2-2026 |
|---|---|---|
 | NonUS | $1M |
ETFS HOLDING THIS STOCK
ETFS HOLDING
14
LISTED HERE
4
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
55.23%
HOLDERS
149
TOP 12 OF 149 · RANKED BY POSITION SIZE
Madryn Asset Management, LP
Ubs Group AG
Vanguard Group Inc
Balyasny Asset Management L.P.
Blackrock, Inc.
Lane Generational LLC
Kent Lake Capital LLC
Fourworld Capital Management LLC
Wexford Capital LP
Jane Street Group, LLC
Masters Capital Management LLC
Geode Capital Management, LLC
RATINGS SNAPSHOT
Overall rating: C
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score2
INSIDER TRADES
★
10 PERCENT OWNER
Chernett Jorey
Purchase · 14.0K shares
2026-08-14
★
10 PERCENT OWNER
Chernett Jorey
Sale · 100 shares
2026-08-13
★
OFFICER: EVP, CFO & TREASURER
Naor Nir
Purchase · 500.0K shares
2026-07-23
★
Naor Nir
— · —
2026-07-23
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 2
2 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 OABI | $4.47 | COMPARE |
 PRE | $25.76 | COMPARE |
 PROF | $6.85 | COMPARE |
 OSUR | $3.60 | COMPARE |
 CDXS | $1.59 | COMPARE |
 NYXH | $1.60 | COMPARE |